原发性高血压采用缬沙坦联用养血清脑颗粒治疗的临床体会.docVIP

原发性高血压采用缬沙坦联用养血清脑颗粒治疗的临床体会 　　doi：10.3969/j.issn.1007-614x.2014.21.58 　　摘 要 目的：探讨缬沙坦联合养血清脑颗粒治疗原发性高血压的临床疗效。方法：2013年3月-2014年3月收治原发性高血压患者88例，分为观察组和对照组各44例。均予以缬沙坦治疗，观察组加用养血清脑颗粒进行联合治疗。对两组治疗前后血压变化情况及不良反应发生情况进行观察和统计。结果：观察组治疗前后收缩压和舒张压的改善情况明显优于对照组 （P0.05）；观察组不良反应发生率明显低于对照组（P0.05）。结论：缬沙坦联合养血清脑颗粒治疗原发性高血压的临床效果显著，有效改善了患者的血压指标，值得推广。 　　关键词 缬沙坦 养血清脑颗粒 原发性高血压 临床效果 　　Clinical experience of the valsartan combined with Yang Xue Qing Nao granule in the treatment of essential hypertension 　　Linghu Bin 　　Department of Cardiology，the Traditional Chinese Medicine Hospital of Linyi County，Yuncheng City，Shanxi 044100 　　Abstract Objective：To investigate the clinical efficacy of valsartan combined with Yang Xue Qing Nao granule in the treatment of essential hypertension.Methods：88 cases with essential hypertension were selected from March 2013 to March 2014.They were divided into the observation group and the control group with 44 cases in each.All of them were treated with valsartan.The observation group were treated with combined with the Yang Xue Qing Nao granule.We observed and statisticed the changes in blood pressure before and after treatment in two groups and the incidence of adverse reactions.Results：The improvement of systolic and diastolic blood pressure of the observation group were better than that of the control group（P0.05）.The incidence of adverse reaction of observation group was lower than that of the control group（P0.05）.Conclusion：The clinical effects of valsartan combined with Yang Xue Qing Nao granule in the treatment of hypertensive cerebral is significantly.It can improve the blood pressure index of patients.So it is worthy of promotion. 　　Key words Valsartan；Yangxueqingnao Granule；Essential hypertension；Clinical effect 　　2013年3月-2014年3月收治原发性高血压患者88例，进行临床治疗期间分组予以缬沙坦单用治疗及缬沙坦联合养血清脑颗粒治疗，取得了不同的治疗效果，现将具体情况报告如下。 　　资料与方法 　　2013年3月-2014年3月收治原发性高血压患者88例，所有患者经临床检查均符合原发性高血压的诊断标准[1]，经尿常规、肾功能检查以及心脏彩超等辅助检查均已证实确诊。采用摸球法将其平均分为观察组和对照组。观察组44例，男28例，女16例；年龄42～75岁，平均（56.2±6.3）岁。